Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acasti Pharma Inc
ACST
Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the...
brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(6)
•••
Ryeman40
X
View Profile
View Bullboard History
Comment by
Ryeman40
on Jun 29, 2020 6:19pm
RE:RE:T2 FDA Discussions
Thats what i was writing about this morning. Seems confusing they would even write that then say they have to stick to original. Horrible cc. I've been a shareholder for 3 yrs now and they didnt
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 6:11pm
RE:T2 FDA Discussions
VERY good question. Did not notice that part in the PR as I was so focused on the data. FDA previously stated things are to stay "status quo" meaning no change on the ITT population.
...more
Silvercorp to Acquire Adventus, Creating a Diversified Mining Company
posted May 02, 2024 9:00am by
Adventus Mining Corp.
-
|
Under the terms of the Arrangement Agreement, each holder of the common shares of Adventus will receive 0.1015 of one Silvercorp common share in exchange for each Adventus Share at the effective time of the Transaction. The Exchange Ratio implies consideration of C$0.50 per Adventus Share ...read more
(75)
•••
QualityTest
X
View Profile
View Bullboard History
Post by
QualityTest
on Jun 29, 2020 5:32pm
T2 FDA Discussions
I haven't had time to listen to the whole CC, but the PR this morning states: " Acasti will now finalize the Statistical Analysis Plan (SAP) for TRILOGY 2, which we plan to submit
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 5:18pm
RE:Incorrect design trial
Every word you are stating Francine - I agree with 100%. The BOD had the chance to flush Jan out last year but Haywood came to her rescue (don't know why?). We are stuck with her incompetence and
...more
(52)
•••
Francine01
X
View Profile
View Bullboard History
Post by
Francine01
on Jun 29, 2020 4:59pm
Incorrect design trial
More I think about this call, more I think they incorrectly design the trial and won't ever admit, Jan need to be replaced. Its impossible that they can't control a placebo arm. If its
...more
(51)
•••
Canadian_101
X
View Profile
View Bullboard History
Post by
Canadian_101
on Jun 29, 2020 4:24pm
Down again when is the next ride
??
(18)
•••
EternalPonzi
X
View Profile
View Bullboard History
Comment by
EternalPonzi
on Jun 29, 2020 3:36pm
RE:RE:Horrible call
As predicted self interest defining factor. Major dilution coming. They no longer have the time to progress their plan. Heads must roll. For those of you that professed pie in the sky claims that
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Post by
Rosmorduc
on Jun 29, 2020 2:45pm
Look at the data, not management
We all know Jan in a disaster and Haywood needs to step in and show her the door. This should have been done a long time ago (like a year ago). CAPRE itself works wonders and that's not my
...more
(77)
•••
Rosmorduc
X
View Profile
View Bullboard History
Comment by
Rosmorduc
on Jun 29, 2020 2:23pm
RE:Horrible call
They know what is going on. They have the audit study, they have the data in front of them, they know what questions are coming. So are they just acting ignorant on purpose or what? All they
...more
(51)
•••
Canadian_101
X
View Profile
View Bullboard History
Comment by
Canadian_101
on Jun 29, 2020 2:20pm
RE:RE:Horrible call
Correct, unfortunately she also said a lot of other things that were ums and a whole lot of I don't know, after listening to the entire call I am not walking away full of confidence, seems like
...more
(52)
•••
Francine01
X
View Profile
View Bullboard History
Comment by
Francine01
on Jun 29, 2020 2:19pm
RE:Horrible call
Agree. horrible call. They basically don't know what happed. They even don't know what was the average mg/dl at week 0 for placebo and Capre arms before and after had hoc analysis. This
...more
(1849)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 29, 2020 2:15pm
RE:Horrible call
Jan said there is a precedent for combining study results to get enough data points for statistical significance.
(51)
•••
Canadian_101
X
View Profile
View Bullboard History
Post by
Canadian_101
on Jun 29, 2020 2:12pm
Horrible call
Seems like they have had no control on the trial and have no idea whats going on......all hopes are on T2 results.....hard to believe they are on an investors call and are talking to one another and
...more
(1849)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 29, 2020 1:25pm
RE:RE:RE:News
I guess co. will have to lock patients in a room without food for 12 hrs to comply.
(1849)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 29, 2020 1:23pm
RE:RE:News
Mentioned in cc that patients may have not fasted adequately before being tested for TG and misrepresented their status.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon